These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

864 related items for PubMed ID: 27154510

  • 21. Long-term clinical outcomes in patients with viral hepatitis related liver cirrhosis after transjugular intrahepatic portosystemic shunt treatment.
    Teng D, Zuo H, Liu L, Dong J, Ding L.
    Virol J; 2018 Oct 01; 15(1):151. PubMed ID: 30285813
    [Abstract] [Full Text] [Related]

  • 22. Refining prediction of survival after TIPS with the novel Freiburg index of post-TIPS survival.
    Bettinger D, Sturm L, Pfaff L, Hahn F, Kloeckner R, Volkwein L, Praktiknjo M, Lv Y, Han G, Huber JP, Boettler T, Reincke M, Klinger C, Caca K, Heinzow H, Seifert LL, Weiss KH, Rupp C, Piecha F, Kluwe J, Zipprich A, Luxenburger H, Neumann-Haefelin C, Schmidt A, Jansen C, Meyer C, Uschner FE, Brol MJ, Trebicka J, Rössle M, Thimme R, Schultheiss M.
    J Hepatol; 2021 Jun 01; 74(6):1362-1372. PubMed ID: 33508376
    [Abstract] [Full Text] [Related]

  • 23. [MELD score in prediction of early mortality in patients suffering refractory ascites treated by TIPS].
    Fejfar T, Safka V, Hůlek P, Vanásek T, Krajina A, Jirkovský V.
    Vnitr Lek; 2006 Sep 01; 52(9):771-6. PubMed ID: 17091599
    [Abstract] [Full Text] [Related]

  • 24. Abnormal portal venous flow at sonography predicts reduced survival after transjugular intrahepatic portosystemic shunt creation.
    Harrod-Kim P, Waldman DL.
    J Vasc Interv Radiol; 2005 Nov 01; 16(11):1459-64. PubMed ID: 16319151
    [Abstract] [Full Text] [Related]

  • 25. Early TIPS with covered stents versus standard treatment for acute variceal bleeding in patients with advanced cirrhosis: a randomised controlled trial.
    Lv Y, Yang Z, Liu L, Li K, He C, Wang Z, Bai W, Guo W, Yu T, Yuan X, Zhang H, Xie H, Yao L, Wang J, Li T, Wang Q, Chen H, Wang E, Xia D, Luo B, Li X, Yuan J, Han N, Zhu Y, Niu J, Cai H, Xia J, Yin Z, Wu K, Fan D, Han G, AVB-TIPS Study Group.
    Lancet Gastroenterol Hepatol; 2019 Aug 01; 4(8):587-598. PubMed ID: 31153882
    [Abstract] [Full Text] [Related]

  • 26. Transjugular intrahepatic portosystemic shunt. Experiences at a liver transplantation center.
    Hidajat N, Vogl T, Stobbe H, Schmidt J, Wex C, Lenzen R, Berg T, Neuhaus P, Felix R.
    Acta Radiol; 2000 Sep 01; 41(5):474-8. PubMed ID: 11016769
    [Abstract] [Full Text] [Related]

  • 27. Combination of Model for End-Stage Liver Disease (MELD) and Sarcopenia predicts mortality after transjugular intrahepatic portosystemic shunt (TIPS).
    Delgado MG, Mertineit N, Bosch J, Baumgartner I, Berzigotti A.
    Dig Liver Dis; 2024 Sep 01; 56(9):1544-1550. PubMed ID: 38555198
    [Abstract] [Full Text] [Related]

  • 28. Covered stents are better than uncovered stents for transjugular intrahepatic portosystemic shunts in cirrhotic patients with refractory ascites: a retrospective cohort study.
    Maleux G, Perez-Gutierrez NA, Evrard S, Mroue A, Le Moine O, Laleman W, Nevens F.
    Acta Gastroenterol Belg; 2010 Sep 01; 73(3):336-41. PubMed ID: 21086935
    [Abstract] [Full Text] [Related]

  • 29. Hemodynamic and metabolic effects of transjugular intrahepatic portosystemic shunt (TIPS) during anesthesia for orthotopic liver transplantation.
    Antonini M, Della Rocca G, Pugliese F, Pompei L, Maritti M, Coccia C, Gasparetto A, Cortesini R.
    Transpl Int; 1996 Sep 01; 9(4):403-7. PubMed ID: 8819278
    [Abstract] [Full Text] [Related]

  • 30. Transjugular intrahepatic portosystemic shunt for recompensating decompensated cirrhosis?
    Karagiannakis DS.
    World J Gastroenterol; 2024 May 28; 30(20):2621-2623. PubMed ID: 38855160
    [Abstract] [Full Text] [Related]

  • 31. Long-term effects and complications of the transjugular intrahepatic portosystemic shunt: a single-centre experience.
    Kraglund F, Jepsen P, Amanavicius N, Aagaard NK.
    Scand J Gastroenterol; 2019 Jul 28; 54(7):899-904. PubMed ID: 31203699
    [Abstract] [Full Text] [Related]

  • 32. Clinical outcome comparison between TIPS and EBL in patients with cirrhosis and portal vein thrombosis.
    Wang Z, Zhao H, Wang X, Zhang H, Jiang M, Tsauo J, Luo X, Yang L, Li X.
    Abdom Imaging; 2015 Aug 28; 40(6):1813-20. PubMed ID: 25504374
    [Abstract] [Full Text] [Related]

  • 33. Survival benefit of TIPS versus serial paracentesis in patients with refractory ascites: a single institution case-control propensity score analysis.
    Gaba RC, Parvinian A, Casadaban LC, Couture PM, Zivin SP, Lakhoo J, Minocha J, Ray CE, Knuttinen MG, Bui JT.
    Clin Radiol; 2015 May 28; 70(5):e51-7. PubMed ID: 25758602
    [Abstract] [Full Text] [Related]

  • 34. FIPS Score for Prediction of Survival After TIPS Placement: External Validation and Comparison With Traditional Risk Scores in a Cohort of Chinese Patients With Cirrhosis.
    Yang C, Chen Q, Zhou C, Liu J, Huang S, Wang Y, Wang C, Ju S, Chen Y, Li T, Bai Y, Yao W, Xiong B.
    AJR Am J Roentgenol; 2022 Aug 28; 219(2):255-267. PubMed ID: 35138134
    [Abstract] [Full Text] [Related]

  • 35. Outcomes of surgical shunts and transjugular intrahepatic portasystemic stent shunts for complicated portal hypertension.
    Hosokawa I, Adam R, Allard MA, Pittau G, Vibert E, Cherqui D, Sa Cunha A, Bismuth H, Miyazaki M, Castaing D.
    Br J Surg; 2017 Mar 28; 104(4):443-451. PubMed ID: 28079252
    [Abstract] [Full Text] [Related]

  • 36. Utility of transjugular intrahepatic portosystemic shunts in liver-transplant recipients.
    Choi DX, Jain AB, Orloff MS.
    J Am Coll Surg; 2009 Apr 28; 208(4):539-46. PubMed ID: 19476787
    [Abstract] [Full Text] [Related]

  • 37. Rapid change of liver stiffness after variceal ligation and TIPS implantation.
    Piecha F, Paech D, Sollors J, Seitz HK, Rössle M, Rausch V, Mueller S.
    Am J Physiol Gastrointest Liver Physiol; 2018 Feb 01; 314(2):G179-G187. PubMed ID: 29051188
    [Abstract] [Full Text] [Related]

  • 38. Transjugular Intrahepatic Portosystemic Shunts With Covered Stents Increase Transplant-Free Survival of Patients With Cirrhosis and Recurrent Ascites.
    Bureau C, Thabut D, Oberti F, Dharancy S, Carbonell N, Bouvier A, Mathurin P, Otal P, Cabarrou P, Péron JM, Vinel JP.
    Gastroenterology; 2017 Jan 01; 152(1):157-163. PubMed ID: 27663604
    [Abstract] [Full Text] [Related]

  • 39. Episodic overt hepatic encephalopathy after transjugular intrahepatic portosystemic shunt does not increase mortality in patients with cirrhosis.
    Nardelli S, Riggio O, Marra F, Gioia S, Saltini D, Bellafante D, Adotti V, Guasconi T, Ridola L, Rosi M, Caporali C, Fanelli F, Roccarina D, Bianchini M, Indulti F, Spagnoli A, Merli M, Vizzutti F, Schepis F.
    J Hepatol; 2024 Apr 01; 80(4):596-602. PubMed ID: 38097113
    [Abstract] [Full Text] [Related]

  • 40. Transjugular intrahepatic portasystemic shunt vs surgical shunt in good-risk cirrhotic patients: a case-control comparison.
    Helton WS, Maves R, Wicks K, Johansen K.
    Arch Surg; 2001 Jan 01; 136(1):17-20. PubMed ID: 11146768
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 44.